Obstetrical, fetal, and lactation pharmacology —a crisis that can no longer be ignored

The data available to inform pregnant and lactating women about drug safety and efficacy are woefully inadequate. This lack of information encompasses every aspect of pharmaceutics, including limited human data about the embryonic risk, limited pharmacokinetic and pharmacodynamic information during and after pregnancy to ensure proper dosing, and a dearth of new medications to treat obstetrical and lactation disorders. This state of affairs has been longstanding and can be attributed to several realities, most of which have withstood any efforts to modify them.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Expert Reviews Source Type: research